Why Are Clinical Trials Vital To Precision Medicine Industry Growth?

The global precision medicine market is projected to be worth USD 738.8 billion by 2030, growing at a CAGR of 12.1%, according to P&S Intelligence. This growth can be credited to the growing government aid for advancing the knowledge regarding personalized treatments, the growing count of accepted personalized medicines, the increasing medicinal tourism industry, and the rising utilization of artificial intelligence in precision drugs.

On the basis of type, the personalized medical care category is projected to experience the fastest development in the precision medicine industry in the coming few years. This can be credited to the increasing subsidy and allowances from the private and public sectors for telemedicine, the growing requirement for remote patient monitoring facilities, and growing cases of hereditarily variable chronic illnesses.

In recent years, the North American region held the largest share in the industry for precision medicine, and the region is also projected to be dominant in the future as well. This growth can be ascribed to the growing occurrence of chronic and lifestyle-related illnesses, like cardiovascular diseases and diabetes increasing the count of government steps, like subsidy and awareness events, for precision drugs; rising per-capita income, and rising healthcare investments.

Numerous government establishments and pharmacological businesses are presently involved in clinical trials for the precision drug. For example, the National Cancer Institute (NCI) advanced a project, called Molecular Analysis for Therapy Choice (MATCH), in 2018 to perform clinical trials about precision drugs and treat cancer tumors in around 6,000 people. Furthermore, the decentralized technique plays an important role in precision medicine trials, as patients can be evaluated remotely at their house, which decreases the travel price and time, thus leading to a higher patient involvement rate.

The steps being taken by governments for emerging modified treatment are playing an important role in the development of the precision medicine industry. As per the Personalized Medicine Coalition, a national health council situated in Washington D.C., U.S., in 2019, the Trump administration aimed to bring the medication costs in the U.S. down, to make them similar to global prices.

The announcement was specifically taken to technologically enhance personalized treatments and make them reasonable for the common people. Furthermore, as per the World Economic Forum, in 2017, Argentina introduced a Precision Medicine Initiative Grant to initiate the scientific trials needed to put the new precision medicine methods into medical practice.

The precision drug has been accepted by healthcare organizations and patients for cancer, CVDs, and communicable illnesses, worldwide. It aids in averting adverse medication reactions and surges the count of treatment possibilities, which has already been boosting the medicinal tourism sector in emerging nations.

Hence, the growing government aid for advancing the knowledge regarding personalized treatments, the growing count of accepted personalized medicines, the increasing medicinal tourism industry, and the rising utilization of artificial intelligence in the precision drug are the major factors contributing to the growth of the precision medicine market.

Read More

Anxiety and Depression Treatment Industry Was Led by Hospital Pharmacies

The anxiety and depression treatment market will progress at a rate of 3.3% in the years to come, to reach USD 24,467.7 million by 2030.

The main factors accountable for the growth of the industry contain increasing elderly population, increasing consciousness about mental ailments and their treatment, and the growing count of product approvals.

The drugs category had larger share in the industry in the past, and it will retain its position in the years to come. This is majorly because of the growing count of product launches, initiatives of the private and public health institutions to spread consciousness pertaining to mental ailments, and research projects for mental ailments.

The major depressive disorder category will grow the fastest in the years to come. This can be mostly credited to the increase in count of major depressive ailment cases, together with evolution in public consciousness on this issue, and increase in frequency of screening by people for better mental health.

North America had the largest share in the past, and it will continue like this by the end of this decade. 

This is majorly credited to the increase in the case count of pain, as well as the greater incidence of anxiety and key depressive disorders, growth in consciousness concerning high disposable income, mental health, and surge in count of prescriptions for antidepressants.

The consciousness about mental health has increased globally, as a result of the increased initiatives by public and private healthcare institutions. The WHO declared 10th October as the World Mental Health Day, for increasing awareness, reduce the stigma, deliver access to services, provide different treatment prospects, and support for mental health and the problems associated with it.

The increasing aging population all over the world has a lot to do with the growing anxiety and depression treatments among people.

Read More

How Will Geriatric Population Boom Fuel Active Pharmaceutical Ingredient Demand?

The global active pharmaceutical ingredient (API) market is projected to be worth USD 357,005.7 million by 2030, growing at a CAGR of 6.9%, according to P&S Intelligence. This development can be credited to the increasing elderly populace, the growing occurrence of chronic illnesses, and the rising importance of generics.

In the past few years, the prescription drug category had a larger revenue share in the active pharmaceutical ingredient industry, on the basis of drug type. This can be credited to the growing demand for prescription medications for the supervision of chronic illnesses, throughout the globe.

In recent years, the oncology category held the largest market share, on the basis of therapeutic application. This is mainly because of the high occurrence of cancer and the surge in the requirement for extremely potent APIs (HPAPIs) for the treatment of cancer.

As per the American Cancer Society, approximately 1.9 million fresh cancer cases and 608,570 cancer-associated demises are projected to be reported in the coming few years. Correspondingly, as per the report by the World Health Organization, 2,003,789 cases of diverse kinds of cancer were stated in Southeast Asia and 1,336,026 individuals lost their lives because of them in 2018.

The offline category is projected to experience quicker development in the active pharmaceutical ingredient market in the coming few years, on the basis of distribution platforms. This will mainly be because of the high sales of APIs through this platform, credited to the growing count of contracts with API providers and medication manufacturing businesses, and the well-known offline distribution platforms of the providers.

In the coming few years the North American region is projected to dominate the active pharmaceutical ingredient industry, credited to the rising occurrence of chronic illnesses, growing government emphasis on generic medications, growing demand for specialty and biologics medications, rising count of pharmaceutical research and development activities, and growing technological improvements.

Moreover, individuals are becoming more knowledgeable regarding several lifestyle-related illnesses, which is further boosting the industry development in the continent. As per the Centers for Disease Control and Prevention (CDC), chronic illnesses price USD 3.5 trillion in 2018 to the U.S. healthcare arrangement.

The growing life expectancy and dropping demise rates are the key contributors to the development of the elderly populace. As per the report by the WHO, individuals are living lengthier as the average life expectancy has amplified. This has led to an enormous development in the world’s elderly populace. 

As per the World Population Ageing Report published in 2019, the count of individuals old 65 years and more stood at approximately 703 million, and this populace is projected to touch 1.5 billion by 2050.

Hence, the increasing elderly populace, growing occurrence of chronic illnesses, and rising importance of generics are the major factors propelling the pharmaceutical ingredient market.

Read More

Bio-Based Cosmetics and Personal Care Ingredients | Industry Growth and Future Analysis

The total value of the global bio-based cosmetics and personal care ingredients market was USD 4,550.6 million in 2021, and it will rise at a growth rate of above 5.3% shortly, reaching USD 7,271.7 million by 2030, according to P&S Intelligence.

This growth can be ascribed to the rising cosmetics sector, increasing knowledge about the damaging effects of artificial chemicals, and the rising effect of marketing approaches on customer trust are some of the robust factors driving the development of the industry.

In 2021, the bio-based ingredients utilized in skin and sun care solutions made approximately USD 2 billion in revenue. Such elements hold the largest share of the industry, and they are projected to remain in the top spot in the future as well.

North America dominated the bio-based cosmetics and personal care ingredients industry with around 45% share, in 2021. The growing customer focus toward multifunctional personal care items, demanding lifestyles, and growing working populace are driving the development of the market in the continent.

North America is a key industry for skincare and haircare items because of the growing knowledge among individuals on skin and hair care especially in the male populace. 

The high disposable revenue in North America also helps the demand for haircare and skincare products, which boosts the need for bio-based elements in the continent.

Increasingly, individuals are turning more worried about their looks, so they are looking for improved substitutes to the old-style cosmetic items in the industry. 

Establishments are investigating deeper into all thinkable aspects of attractiveness and well-being, examining customer behavior and prettiness aspirations, understanding the ecology of the hair and skin, and refining sustainable growth approaches.

Hence, the rising cosmetics sector, increasing knowledge about the damaging effects of artificial chemicals, and the rising effect of marketing approaches on customer trust are some of the robust factors driving the development of the industry.

Read More

Why Online Pharmacies are Becoming a Trend?

The global E-pharmacy market was valued at USD 68,382.3 million in 2021 and will grow at a rate of about 16.1% during 2021–2030, reaching USD 261,684.5 million by 2030, according to P&S Intelligence.

This can be credited to the increasing count of internet users, wide access to online services, and the rising utilization of e-medicines in hospitals and other healthcare sceneries.

Additionally, the surge in teleconsultation and analytic aid boosts the e-pharmacy industry development. Over the years, healthcare amenities for the management of chronic illnesses have been the stamp of medical aid.

However, with the launch of teleconsultation, treatment ways have altered throughout the globe. These days, e-prescriptions can be produced via remote conferences, which can be utilized to buy medications via online pharmacies. This has directed to savings in patients' time and a surge in the effectiveness of healthcare workers.

The industry for online health care and nutrition items is projected to develop with the highest CAGR, of approximately 17%, in the coming few years. This is mainly because of the increasing knowledge regarding nutritional items, and the increase in the sales of such products in the past few years, mostly during the pandemic time. 

According to a study, roughly 50% of U.S. consumers order health wellness and nutritional items via online platforms, and this trend is projected to be followed in the future as well.

In 2021, Online pharmacy items sold via app-based channels were valued at approximately USD 40 billion. The surge in mobile utilization and internet saturation, and the increase in the count of individuals doing online payments have elevated the demand for online medications via app-based channels in the past few years.

North America had the largest revenue share, of above 40%, in the online pharmacy market. This can be ascribed to the high internet usage and augmented knowledge about online OTC medications. For example, approximately 90% of the North American populace utilizes the Internet.

Furthermore, the occurrence of chronic illnesses in Canada and the U.S. is growing swiftly. 6 out of 10 adults in the country are suffering from a chronic illness. The U.S. healthcare system invested approximately USD 4.0 trillion yearly, which is flooring the way for the growth of online drugstores in the continent. 

Furthermore, the increasing pharmaceutical medication sales in the continent also strengthens the growth of the market. For example, in 2021, North America had approximately 50% of total world medicinal sales.

Hence, the increasing count of internet users, wide access to online services, and the rising utilization of e-medicines in hospitals and other healthcare sceneries are the major factors contributing to the growth of the online pharmacy market.

Browse More Related Reports:

Telemedicine - Industry Trends and Future Scope

Digital Health - Industry Trends and Future Scope

Electronic Health Record - Industry Trends and Future Scope

Read More

Biologics CDMO Market Is Dominated by APAC

The biologics CDMO industry will generate USD 31,839.7 million, growing at a rate of 10.3%, by 2030 as per a report by P&S Intelligence. This is credited to the increasing demand for medicines, growing investment in healthcare infrastructure, the launch of new products, and the increasing elderly population.

Pharma and biotech organizations that require higher capital investments for advanced technologies are partnering with CDMOs, because of the high demand for novel therapeutics and the increasing prevalence of infectious diseases.

In the past few years, the drug substances category accounted for the largest biologics CDMO market share, of more than 50%. This is attributed to the increasing biologics approvals, mainly by the FDA, along with the strong clinical pipelines and decreasing biologic drug development rate of failures.

Mammalian cell culture will contribute a revenue of USD 17,983 million to the biologics CDMO industry in 2030, growing at a rate of more than 10% over this decade. This category will continue to grow as more-complex biologics are developed.

As per the European Federation of Pharmaceutical Industries and Associations (EFPIA), in the past few years, the pharmaceutical industry invested USD 46,144 million in Europe for developing and researching new medicines. The growing demand for pharmaceutical drugs and biologics, along with the enhanced production requirements, have driven CDMOs to engage in research and development.

Furthermore, research and development support the testing and development of novel therapies, clinical testing for safety & marketing, and expansion of product portfolio. Thus, the rising investment in research and development will advance the growth of the industry. 

The pandemic had a positive impact on the industry, due to the high requirement for vaccines and therapeutic antibodies during that time.

APAC is an evolving market, which attracts the attention of biologics contract manufacturing and development organizations. APAC will remain the largest and fastest-growing region, with a compound annual growth rate of more than 10% throughout this decade. This is credited to the enormous and rapidly increasing population, which is demanding better access to medicines.

Moreover, the growth in the region is because of the growing affordability of pharmaceuticals due to the development of low-cost generics. In addition, the increasing number of government healthcare programs, growing urbanization rate, and increasing GDP per capita are thriving CDMO market. 

For instance, India is an exceptional nation for the CDMO industry, as it has highly skilled and qualified workers and has received FDA approvals for numerous drugs.  

It is because of the increasing and aging populace, massive investment in healthcare infrastructure, and the increasing healthcare program by the government, the demand for biologics CDMO will continue to grow in the coming years.

Read More

Medical Radiation Detection, Monitoring & Safety Industry IS Dominated by Hospitals

The total size of the medical radiation detection, monitoring, & safety market was USD 2,140.8 million in 2021, and it will advance at a rate of 8.3% in the years to come, to reach USD 4,373.8 million by 2030.

The high occurrence of cancer, rising elderly population, increasing count of radio and nuclear diagnostic and therapeutic processes, and increasing count of diagnostic imaging centers will power the growth of the industry.

In the recent past, the full-body protection category dominated the industry with about 50%, on segmentation by safety product. 

This category's considerable share might be credited largely to the increasing count of radiological processes and increasing knowledge amongst radiologists, physicians, and patients on the risks of overexposure to radiations.

North America medical radiation detection, monitoring, & safety market had the largest share, and it would grow at a substantial rate, of 8.6%, in the years to come, as stated by a market research firm, P&S Intelligence, in one of its reports.

There is a high prevalence of cancer all over the world, and it is because of this fact, the demand for medical radiation detection, monitoring & safety, is on the rise worldwide.

Read More

Digital Biomarkers Industry To be Dominated by the Asia-Pacific

The total revenue generated by the digital biomarkers market in 2021 was USD 1,850.8 million, and it will advance at a compound annual growth rate of 31.6% in the years to come, to reach USD 21,986.2 million by 2030, according to a market research report, published by P&S Intelligence.

Digital biomarkers are the substance of precision medicine since they offer concrete evidence of patient outcomes.

Furthermore, the healthcare system is moving in the direction of a value-based delivery paradigm, spurred the expansion of state-of-the-art technologies, for example digital biomarkers. The key goal of developing such technology is to advance custom-made care delivery through an improved analysis of patients’ healthcare info.

The increasing occurrence of cardiovascular diseases because of many causes, including high consumption of tobacco, bad eating habits, and extreme alcoholism, will fuel the development of this in the future. Digital biomarkers take in the patient data and improve patient care and outcomes of the treatment.

APAC dominated the digital biomarkers market, with regards to revenue, and it will continue its dominance in the years to come. Recently, the increasing government expenditure on the expansion of cutting-edge healthcare infra has significantly boosted the acceptance of digital biomarkers in the APAC.

The propagation of digital technologies and their snowballing acceptance in the healthcare sector are driving the growth.

China is quickly growing because of the budding acceptance of internet connectivity, mobile phones, and digital health techs, which opened up new pathways for improving non-transmissible disease care delivery and population health management. 

Due to the increasing use of smartphones and internet, the demand for digital biomarkers will continue to grow significantly by the end of this decade.

Read More

North America is Dominating the Downstream Processing Industry

In 2021, the downstream processing market was worth around USD 21.1 billion, and it is projected to advance at a 10.3% CAGR from 2021 to 2030, hitting USD 51.0 billion in 2030, according to P&S Intelligence.

This growth can be ascribed to the fact that the biotechnology industry is expanding worldwide, a quick surge in research and development expenditure In the biopharmaceutical industry, and contract-making organizations gaining traction. Moreover, there have been implausible opportunities in the biotechnology sector, which have enhanced the growth of the industry on a universal level. 

On the basis of application, the antibodies production category is projected to experience the fastest development, growing at a CAGR of approximately 10.9% during the forecast period. Due to the surged requirement for monoclonal antibodies, the need for antibody creation is increasing at the highest rate. The launch of modern items for the efficient purification of antibodies also contributes to the growth of the industry.

In 2021, the chromatography system category dominated the downstream processing market and held the largest revenue share, of 37.5%, on the basis of product type. Constant research and development activities to enhance the speed and effectiveness of chromatography systems are projected to boost industry growth.

In the coming few years, the solid-liquid separation category is predicted to experience the highest CAGR. This can be ascribed to the fact that the solid-liquid separation method has several benefits, such as being more suitable for constant mode production, cost-efficient, and simplicity. Additionally, this kind of filtration might also be easy to apply to an extensive variety of pharmaceutical applications, because of its versatile nature.

Mainly because of rapid growth in research and development efforts in order to enhance bioprocess technologies, high throughput process expansion, constant downstream processing for multicomponent separations and perfusion chromatography systems, and the acceptance of high-resolution membrane systems. This has led to the elevation in the need for improved and enhanced bioprocessing technologies for addressing the purification of a bottleneck.   

In 2021, North America led the industry and generated the largest revenue share of approximately 32.4%. This can be ascribed to the several government initiatives to support bioprocess technologies, increasing medical investment, and advanced healthcare infrastructure.

Furthermore, the continent has experienced major cooperative activities with healthcare key players that are heavily spending on the research and development of vaccines and biopharmaceuticals.

Hence, the biotechnology industry is expanding globally, the quick surge in research and development expenditure in the biopharmaceutical industry, and contract-making organizations gaining traction, and also there have been implausible opportunities in the biotechnology sector, such factors are contributing to the growth of the downstream processing industry.

Read More

Increasing Demand for Cardiac Biomarkers Due to Growing Prevalence of Heart Attacks

During heart damage, or distress, several components are released into the blood, which is further measured to help in diagnosing cardiac ischemia, acute coronary syndrome, and conditions affecting the heart palpitation, such as insufficiency of blood flow to the heart. Such components or substances are known as cardiac biomarkers. These are tested to help in diagnosing the cardiac disease risk or supporting in monitoring and managing cardiac ischemia and ACS in patients.

Cardiac ischemia and ACS are usually caused by plaque formation in artery walls, and atherosclerosis. It might cause severe narrowing of arteries due to blockage of blood flow or insufficiency of oxygen. Individuals may feel prolonged chest pain due to sudden decline in the blood flow, and it may cause non-functioning of heart cells as they get dead. Such a condition is known as acute myocardial infarction or heart attack. This may result in the death of the affected part of the heart or heart scarring, and it may also cause sudden death of the individual due to irregular heart contractions.

Browse detailed report on Cardiac Biomarkers Industry Analysis and Forecast Report 2030

Types of Cardiac Biomarkers

Troponin: It is the most commonly ordered cardiac marker. This cardiac marker is elevated within a few hours of heart damage and kept elevated for up to two weeks. Increasing the frequency of troponin tests performed within several hours helps in diagnosing a heart attack.

High-Sensitivity Troponin: High-sensitivity troponin test is done to detect protein in the standard test, compare to lower levels. This test is more sensitive, compared to positive sooner, and helps in detecting ACS faster than the standard test. This is a positive test in people having stable angina, reflecting no symptoms.

Creatine kinase (CK) and CK-MB: On several occasions, CK can be utilized to detect the second heart attack occurring more frequently after the first. Moreover, CK-MB is a standard form of creatine kinase enzyme usually found in heart muscle. Its level rises when the muscle cells of the heart get damaged and can be utilized in following up on CK elevation, during the absence of the troponin test. 

Myoglobin: Myoglobin testis is used with troponin for early detection of a heart attack.

Hs-CRP: This test is performed to detect the future prevalence of heart attacks in people who have already experienced one in the past.

BNP (or NT-proBNP): This test is utilized to recognize heart failure. People with high-risen levels of ACS reflect a high risk of recurrent events.

On the horizon: These biomarkers can only be found in research settings, as they are not utilized for clinical practice. These biomarkers are being investigated to determine their potential use in measuring the ACS.

General Laboratory Tests: These tests are conducted to evaluate the general health status of the person, including their kidney, liver, acid or base balance, electrolyte, blood sugar, and blood proteins. 

Non-Laboratory Tests: These tests are conducted to help the health practitioner in diagnosing the size, shape, and heart functioning. They are utilized for the detection of changes in the heart rhythm as well as blocked arteries and damaged tissues.

Therefore, the growing prevalence of cardiac diseases, along with heart attacks leads to increased usage of cardiac biomarkers.

Read More

Hematology Testing Industry WAS Dominated by Hospitals

The hematology testing market will reach USD 6,335.9 million by 2030, at a rate of 6% in the years to come, as stated by a market research institution, P&S Intelligence.

This growth of the industry is mainly because of the rising incidence of diseases related with blood and the increasing acceptance of high output hematology analyzers along with tech progressions.

Consumables had a larger share of revenue, of about 70%, in 2022, and it will continue to grow with a rate of about 7% in the future. This is because of the widespread use of various test kits and reagents for performing hematology testing, while catering to the necessities of end users.

These are measured to be the reoccurring revenue model. The consumables are the need of the hour every time hematology testing is done, building a directly relational relationship between instruments and consumables.

Among consumables, reagents dominated the industry with about 60% in 2022, and it will grow the fastest with about 5% in the years to come. This is because of the increasing count of lab tests, as a result of the increasing occurrence of infectious and chronic diseases.

Similarly, the increasing usage of IVD testing in continuing research events and the growing IVD product introductions will improve the acceptance of reagents, at a global level.

Routine hematology tests had a larger share, of about 70%, in 2022. Tech progressions have brought about a better comprehending of the relationship between routine tests and numerous disease indications.

This has led to an increase in routine tests performed for determining a number of health conditions. CBC is a common routine test. One of the main reasons for the growing count of CBC tests is their user-friendliness.

Hospitals led the hematology testing market, with a share of approximately 45%, in 2022. This is because of the snowballing number of hospitals and high patient arrival in hospitals as opposed to further diagnostic centers.

Likewise, hospitals create contracts with vendors for purchasing analyzers and related consumables regularly. Furthermore, the requirement for hematology testing amongst patients is high, suffering from diabetes and cancer.

North America was the market leader in the past, with about USD 2 billion. This has a lot to do with the increasing incidence of numerous blood disorders, promising patient demographic, and compensation policies.

The requirement is mostly increasing across professional healthcare settings for treating the increasing population of patients in Canada and the U.S.

Also, the increasing occurrence of sickle cell disease, anemia, and thalassemia, are powering the requirement for consumables and hematology analyzers in North America.

It is because of the increasing requirement for personalized product recommendations, the demand for hematology testing solutions will continue to increase in the years to come.

Read More

Hemato Oncology Testing-The Initial Step for Diagnosing Blood Cancer

Hearing the word hemato oncology testing, some of the people might get frightened or some of them may also fail to understand it altogether. Well, to simplify it, hemato-oncology testing is the test conducted for determining, whether an individual is suffering or has a potential risk of developing a blood-cancer.

In this blog we will focus on the concept of hemato oncology and the various aspects, which are associated with it.

First of all, we will learn about, who on earth are hematologic oncologists

Hematologic oncologists are the people, trained in the diagnosing, treating and preventing blood cancers and blood disorders. These medics use a variety of tools, for instance imaging and lab tests, and provide medical therapies for patients suffering from blood cancers or other blood disorders.

Hematologic malignancies are very different from other cancers as they develop in the cells of the body and might not formulate tumors. Some hematologic oncologists only specialize in treating solid tumors, and do not treat any other kind of cancer.

Why a Hematologic Oncologist Should be Consulted?

These professionals can be consulted in case of an abnormality found in a blood test. The blood consists of WBCs known as the warrior cells that fight any kind of infection, RBCs carrying oxygen from the lungs to the heart and also the other body parts, platelets which are responsible for clotting of blood and preventing uncontrolled bleeding, and plasma carrying waste to the liver and kidneys.

There might be too many or too few of any of these components in the blood, which would be analyzed by hematologic oncologist for finding out any symptoms of signs of malignancies in blood or other issues associated with blood. Multiple myeloma, such as, may arise in the plasma in bone marrow, and Hodgkin lymphoma can develop in lymphocytes.

When the testing is done, and if a malignancy in the blood is diagnosed, it is to be treated, and that too will be done by these hemato-oncologists.

Let’s see, how blood cancer is treated by these professionals

Treating blood cancer depends on various factors, such as the cancer type, age, progression rate and the site of the cancer.

Those suffering from blood cancer are treated the hematologic malignancies specialists, reducing the prospect of a relapse and offer helpful patient care for keeping them strong, reducing side effects of medications and maintaining their quality of life.

A hematologic oncologist will develop a complete treatment plan including targeted therapy, radiation, chemotherapy and also stem cell transplantation.

For helping reducing or preventing the side effects of treatment and speed up the recovery, you may be recommended a range of supportive care services, including nutritional or naturopathic support, managing pain and counselling.

The initial step is the hemato-oncology testing, and it is only after that, any treatment can be administered. Due to the rising prevalence of blood cancers, the demand for hemato-oncology testing is on the rise, and will reach USD 8,594 million by the end of this decade.

Read More

Omnipresent Risk of Future Infection Outbreaks Driving Rapid Test Kit Industry

There is no doubt that the pandemic has considerably slowed down in the recent past, but it is really hard to forget the situation which was there during the time, when the virus started to manifest itself all over the world. The WHO has not released an official statement that the COVID-19 is over, so it can be said that COVID is far from over.

When the was as its peak, there as an increased need for rapid test kits all over the world. Rapid test kits are two types, rapid antigen test, and rapid antibody tests.

Rapid antigen tests and antibody tests were used to discover whether a person is suffering from the infection or not. In this blog, you will get to know about some of the benefits of using the COVID-19 kits, that were essentially the rapid test kits.

Returning To Work is Safer

Many businesses were down for quite a while during the full swing of the deadly virus, keeping in mind the health and wellbeing of their employees as well as other people around them. There were many people infected with the virus, all over the world, and most of them were completely unaware of the fact that, they are infected.

This was especially the case with the asymptomatic cases, where there were no visible symptoms of the infection. Upon going to work or anywhere out in the public domain an asymptomatic person could infect other people as well. A rapid test kit can prevent this deadly situation from taking place helping people gain insight on their health status before being out in the public domain.

People are Not Left in the Dark

The rapid test kits used to test people for the virus come in handy for providing answers to the questions by stating the precise test results. Whether the results are negative or positive, people are at least clear of the whole situation and can take the apt action to take care of themselves and the ones around them as well.

Help Limit the spread of the Virus

Rapid test kits can provide people with appropriate health consciousness and accountability to decrease the spread of the virus. With the help of testing, infected people can properly quarantine and avoid spreading the virus.  The people who are not feeling well can get tested, and by doing this they can save a million lives.  The people tested positive can avoid coming in contact with the people, who are uninfected.

Overall, COVID-19 antibody test kits are tremendously useful. These kits offer an improved mental state for the people, safer environment to work, and decrease the spread of the virus. These rapid test kits have really proved their worth during the time, when the virus was going, full-throttle.

It is because of the increase in awareness of the early diagnosis of the disease, such as the COVID-19, the demand for rapid test kits is on the rise, and will reach a total value of USD 46,139.9 million by the end of this decade.

Read More

How Social Media Influences Our Attitude To Health and Food

Most skin doctors and other skin-care specialists say that the foods we intake affect the well-being of our skin. Some foods, like which are in sugar, can help you in achieving clear, acne-free skin. And, some foods make it simpler to attain healthy, glowing skin.

The global skin health foods market is experiencing growth and is projected to reach USD 3,438.9 million by 2030.

How Social Media Influences Our Attitude To Health and Food

• It can inspire experimentation with diverse foods. We’re more likely to try out a new ingredient if we’ve seen someone else Utilize it and show us how to include it into our daily diet. Accordingly, this can make healthy eating more popular and pleasing as we’re continuously exposed to new and innovative ideas.

• Social media makes nourishment education more reachable. Before social media, we would either have to vigorously seek out education about food which can be costly, time taking, or both. However, in today’s world of social media, we can be continuously exposed to tips and tricks to aid our learning around nutrition and food.

• Active engagement via Instagram and other social media channels permits the user to interact with the creator, ask questions, and learn more. This is a unique and fantastic advantage that social media provides us and one which we simply cannot achieve via reading a book or even scrolling the internet.

• Regular inspiration, if you’re following individuals who keep you attentive and excited about nourishment and living a healthy lifestyle it’s a simple and suitable place to seek that boost of external inspiration which can inspire you to make healthier choices on the tougher days.

Eat These Foods For Healthy, Glowing Skin

Turmeric

Spices also play an important role in eating your way to improve skin, and turmeric is one of the most powerful. The active antioxidant in the spice is called curcumin, and researchers have found that it’s extremely effective at decreeing inflammation and fighting free radicals.

There’s also a study suggesting topical turmeric lessens dark pigmentation and marks instigated by sun exposure, aging, and hormone imbalance. You can mix turmeric and honey for a simple facial mask.

Tomatoes

Tomatoes aid in reducing damage caused by the sun because of their high lycopene content (an antioxidant.) Usually, the redder the tomato the higher the quantity of lycopene. Cooking also supports absorption.

Chia seeds

Eating more chia seeds is a snap since you can mix them into smoothies, sprinkle them over oatmeal or yogurt, or add them to fruit juice and other beverages.

Chia seeds are filled with omega-3 fatty acids. According to experts "Omega-3 fatty acids aid in providing building blocks for healthy skin cell function and new collagen production to maintain the skin foundation robust and wrinkle-free.”

The major reasons ascribed for the sector’s development such as the high occurrence of allergic illnesses, growing consumer consciousness regarding their overall well-being, increasing research and development on and production of functional food and beverage items, and rising consumption of nutrient-rich edible products to encourage overall fitness.

Read More

What Are Two Ways Stomas Are Created and How to Care for Them?

A stoma is an opening in your abdomen that permits waste to remove from your body, rather than going via your digestive system. They’re utilized when part of your bladder or bowels either requires to heal or be detached.

To make a stoma, your surgeon will pull part of your large or small intestine onto the surface of your skin and stitch it onto an opening in your abdomen. The intestine ends and drains waste into an ostomy appliance, which is a bag attached to your stoma. Stomas are generally red, round, and moist, and they measure about 1 or 3 inches wide.

Numerous individuals use the terms “ostomy” and “stoma” interchangeably, but they do have a little different meaning:

An ostomy denotes the real opening in your abdomen.

A stoma denotes the end of the intestine that’s stitched into the ostomy.

Ostomies can be temporary and permanent. If you have an organ that is enduringly damaged, you’ll likely require a permanent one. However, if part of your intestine just requires to heal for a while, you may have a temporary ostomy.

The stoma care market is experiencing growth and is projected to reach USD 3,882.1 million by 2030.

What are the different types?

There are numerous kinds of stoma, reliant on the process utilized to create them:

Colostomy- A stoma is made with part of your colon, also called your large intestine, to avoid your rectum. In some cases, you may have the minor part of your colon removed, directing to a permanent stoma. A colostomy can also be impermanent if your colon is just required to heal. You may require a colostomy if you have rectal or colon cancer, a colon wound, or a blockage in your colon.

Urostomy- Your medic will make a bag using your small intestine. They’ll attach your ureters to this bag so that urine can gutter outside of your body without passing via your bladder. You may require a urostomy if your bladder is unhealthy or injured.

Browse detailed report on Stoma Care Industry Development and Demand Forecast Report 2023-2030

What kind of care is involved?

Your ostomy appliance comprises a bag that your stoma pipes into. Liable on the kind of bag you have, you’ll require to change it every four to seven days. When you change the bag, clean the skin around your stoma with mild warm water and let it dry totally. You don’t require to utilize soap, but if you do, make sure it’s very light and odorless, While the bag is detached, look for any signs of blood, irritation, or variations in the size and color of your stoma.

Colostomy surgery is leading the industry, based on surgery-type segmentation. This can be ascribed to the increasing occurrence of colon cancer and the growing number of colostomy methods.

For example, as per the United Ostomy Associations of America, around 100,000 ostomy operations are done in the U.S. annually.

Hence, the rising aging populace, the mounting board population of people suffering from inflammatory bowel illnesses and bladder and colorectal cancers, improved technology, the growing number of stoma and ostomy operations of the intestine, and fascinating reimbursement systems in developed countries are the major factors driving the market.

Read More

North America Is Dominating Companion Animal Diagnostics Industry

The total value of the global companion animal diagnostics market was USD 2,424 million in 2022, and it will rise at a growth rate of above 9.40% shortly, reaching USD 4,974 million by 2030, according to P&S Intelligence.

This growth can be ascribed to the growing count of animals being accepted as pets worldwide and the increasing demand of pet holders to consider pets as part of the family leading to the universal trend of pet parenting.

In Europe and North America, pets are being accepted as a friend for elder people. Furthermore, with the increasing knowledge regarding pets’ well-being and the improving standards of therapies and treatments for pets, the demand for companion diagnostics is escalating at a significant pace.

On the basis of segmentation, the industry is divided into cats, dogs, and others, among these, in 2022, the dog category had the largest share. This is mainly because of the growing populace and adoption rate of dogs and the increasing frequency of zoonotic illnesses throughout the world, which lead to the rising demand for veterinary appointments and diagnostics for dogs.

In 2022, North America generated the largest revenue share of 41% and is also projected to experience the fastest growth in the coming years. This is because of the rising populace of pet animals, particularly in the U.S.; the increasing pet insurance; and the growing health spending on companions in the continent. For example, as per the American Pet Products Association (APPA), in the U.S., approximately 70% of families owned a pet, as of 2021.

Hence, the growing count of animals being accepted as pets worldwide and the increasing demand of pet holders to consider pets as part of the family are the major factors contributing in the growth of the companion animal diagnostics market.

Read More

Single-Use Bioprocessing Industry Will Grow Fastest in the Asia-Pacific Region

The single-use bioprocessing market will grow at a rate of 17.10% by the end of this decade, to touch USD 80.36 billion by 2030.

Single-use systems are employed at clinical size of more than 80% of bioprocessing processes and will be used by biomanufacturers and CMOs on a larger commercial scale. For scaleup and clinical manufacturing, players now make use of the largest single-use disposable systems, as a result of the development of greater commercial scales, and therefore the requirement for single-use products is on the rise.

Furthermore, vendors are evolving improved disposable technologies with the evolution of the industry, for setting themselves apart from rivals. This is fine news for healthcare providers and CMOs since it will improve competition and lower the pricing.

The industry will observe the wider commercial acceptance of these kinds of products as supervisory agencies become additionally comfortable with their performance. Consequently, the industry will increase considerably beyond its existing size. 

North America had the largest share of revenue. The expansion of the industry is fueled by a surge in the usage of single-use bioprocessing techs for a number of biopharma applications is renowned for its medical services and healthcare facilities.

APAC single-use bioprocessing market will expand at the highest rate in the future. This can be credited to the increasing requirement for bioprocess equipment, for example lab filtration systems and membrane-based microbial analysis devices. 

Furthermore, the pharma and lab equipment industries are observing strong growth, which will provide lucrative prospects for single-use bioprocessing products in the region.

It is because of the improved user-experience protection through cloud systems, the requirement for single-use bioprocessing solutions will continue to grow in the years to come.

Read More

Clinical Nutrition Industry To Observe Highest CAGR In Asia-Pacific

The clinical nutrition market is expected to grow at a rate of 7.2%, to reach USD 70.8 billion by 2030 as per a report by P&S Intelligence. This growth is ascribed to the rising elderly population, increasing malnutrition incidence, adoption of sports nutrition by athletes, rising incidence of lifestyle-related ailments, and a high birth and premature birth rate.

To learn more about this report: https://bit.ly/3NY6a2P

Developing countries of APAC, LATAM, and MEA, for instance, Brazil and India, offer significant growth potential for the industry. Major players are investing in the expansion of their footprint in these regions. The need for clinical nutrition in these regions is rapidly growing, resulting in a growth opportunity for both new entrants and reputed firms. 

Moreover, the increasing awareness regarding nutrition products and the increasing compliance with homecare medical services are driving the demand for the products. 

In the pediatric population, the consumption of clinical nutrition is highest among newborns under the age of one. For parents, the well-being of their children is a priority. This has led the parents to spend more money on their children's treatment. Parents are looking for ways to keep their children healthy, and save unnecessary medical costs. These precautions will boost the industry.

The cancer category is significantly growing in the clinical nutrition market, because of the increasing incidence of cancer. Enteral nutrition products are regarded as the best solutions for cancer treatment, ensuring proper functioning of various organs and preventing nutritional deficiencies. 

The incidence of metabolic diseases is rapidly increasing in adults and the elderly, along with the need for clinical nutrition. Nutrition is vital for the treatment of metabolic diseases. Additionally, the introduction of new products and the growing prevalence of metabolic disorders is boosting the industry's growth. 

North America held the majority of product sales, approximately 40%, in recent years. This is credited to the existence of a large number of players, better reimbursement policies, and an inactive lifestyle. In addition, the developed healthcare facilities, high healthcare expenditures, and high disposable income are also boosting the demand for clinical nutrition. 

Whereas, the APAC has the highest CAGR, of over 9% during the forecast period. This can be ascribed to the increasing elderly population, high rate of malnutrition, and increasing birth rate. As malnutrition treatment cases increase in the region, the demand for therapeutic nutrition products is also increasing. 

In addition, the industry in APAC is expected to be boosted by the increasing healthcare costs, growing nutrition awareness, and rising disposable income. 

Due to the increasing incidence of lifestyle-related diseases, high healthcare expenditures, and the increasing elderly population, the clinical nutrition industry will grow significantly in the coming years.

Read More